EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Efficacy and safety of tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps overall and in patients with and without co-morbid asthma: results from the phase 3 WAYPOINT study

Friday 13 Jun, 15:36 PM - 15:48 PM Glasgow, United Kingdom